Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017

Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017

Background: The DTaP-IPV/Hib combination vaccine can replace the acellular tetanus vaccine, polio vaccine, and the Haemophilus influenzae type B vaccine. Data on the safety of DTaP-IPV/Hib vaccines are required. We aimed to evaluate the safety of the vaccination program. Methods: Using the National...

Full description

Bibliographic Details
Main Authors: Zhiqun Li, Jianxiong Xu, Huifeng Tan, Chunhuan Zhang, Jian Chen, LiHong Ni, Xuexia Yun, Yong Huang, Wen Wang
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:International Journal of Infectious Diseases
Subjects:
Adverse events following vaccination
DTaP-IPV/Hib vaccine
Vaccine safety monitoring
CNAEFIS systems
Post-marketing surveillance
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220305634

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220305634

Similar Items